<DOC>
	<DOCNO>NCT00051753</DOCNO>
	<brief_summary>The purpose study demonstrate non-inferiority levofloxacin compare amoxicillin/clavulanate clinical response end therapy infant child recurrent and/or persistent acute otitis medium .</brief_summary>
	<brief_title>Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media</brief_title>
	<detailed_description>This randomize , active-comparator , multicenter study consist 3 phase : Pretreatment ( Screening ) Phase , Treatment Phase , Posttreatment Phase . Subject eligibility determine screen visit base sign symptom acute otitis medium ( e.g. , middle ear effusion , acute inflammation , acute purulent otorrhea ) criterion recurrent and/or persistent acute otitis medium . Eligible subject randomize drug dispense study coordinator instruct parent subject importance revealing assign therapy subject 's evaluator . Each subject evaluator remain blind subject 's therapy throughout study . Clinical assessment perform blind evaluator several time point throughout study use evaluate efficacy . Safety evaluate throughout study assessment adverse event change physical examination ( include musculoskeletal examination evaluation joint ) , vital sign , clinical laboratory finding . Supplementary safety evaluation musculoskeletal adverse event perform throughout study . All subject enroll study take least 1 dose levofloxacin amoxicillin/clavulanate eligible rollover long-term surveillance study primarily focus musculoskeletal system . The purpose study demonstrate non-inferiority levofloxacin compare amoxicillin/clavulanate clinical response end therapy infant child recurrent and/or persistent acute otitis medium . Either levofloxacin 10 mg/kg twice daily 10 day ( maximum daily dose 500 mg ) amoxicillin/clavulanate ( 14:1 ) 45 mg amoxicillin/kg twice daily 10 day ( maximum daily dose 3600 mg amoxicillin ) . Both study drug give orally liquid suspension formulation</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Males female , age &gt; equal 6 month &lt; 5 year Clinical sign symptom otitis medium include middle ear effusion acute inflammation acute purulent otorrhea At risk difficult treat Acute Otitis Media ( AOM ) define one following : recurrent Otitis Media ( OM ) define 3 episode last 6 month 4 episode past year persistent OM define evidence AOM 3rd day start antimicrobial regimen Written consent/assent Have participate experimental drug medical device trial within 30 day prior start study . History hypersensitivity serious reaction quinolone Tympanostomy tube affect ear Requires use systemic antibiotic study drug Has serious bacterial infection addition AOM may interfere assessment clinical response Diagnosed bacterial meningitis Abnormal renal function define serum creatinine &gt; 0.5 mg/dL infant 6 month old 0.8 mg/dL child 1 5 year age History presence arthropathy periarticular disease musculoskeletal sign symptom may confound future safety exam MS event Has high probability death study Poorly control seizure disorder risk seizures HIV infection require pneumocystis carinii pneumonia prophylaxis Chronic use corticosteroid 2mg/kg 20mg/day 14 day Amoxicillin/clavulanate ( 90 mg/kg/day ) use within 3 day first dose study drug Previous participation protocol another levofloxacin clinical study Employees investigator study center direct involvement study Family member also exclude</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Otitis Media</keyword>
	<keyword>Acute Otitis Media</keyword>
	<keyword>ear infection</keyword>
	<keyword>levofloxacin</keyword>
	<keyword>amoxicillin</keyword>
	<keyword>clavulanate</keyword>
</DOC>